SA516370640B1 - وسيلة وطرق لاستخدام الوسيلة للكشف عن فرط أمونيا الدم - Google Patents
وسيلة وطرق لاستخدام الوسيلة للكشف عن فرط أمونيا الدم Download PDFInfo
- Publication number
- SA516370640B1 SA516370640B1 SA516370640A SA516370640A SA516370640B1 SA 516370640 B1 SA516370640 B1 SA 516370640B1 SA 516370640 A SA516370640 A SA 516370640A SA 516370640 A SA516370640 A SA 516370640A SA 516370640 B1 SA516370640 B1 SA 516370640B1
- Authority
- SA
- Saudi Arabia
- Prior art keywords
- biosensor
- rrr
- sample
- see
- ammonia
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 63
- 206010020575 Hyperammonaemia Diseases 0.000 title claims description 30
- 238000001514 detection method Methods 0.000 title description 23
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims abstract description 152
- 229910021529 ammonia Inorganic materials 0.000 claims abstract description 75
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims abstract description 40
- 239000012528 membrane Substances 0.000 claims abstract description 33
- 239000008280 blood Substances 0.000 claims abstract description 28
- 210000004369 blood Anatomy 0.000 claims abstract description 28
- -1 ammonium ions Chemical class 0.000 claims abstract description 12
- 238000005259 measurement Methods 0.000 claims abstract description 9
- 239000003513 alkali Substances 0.000 claims abstract description 6
- 239000000872 buffer Substances 0.000 claims abstract 5
- 210000001124 body fluid Anatomy 0.000 claims description 66
- 150000001413 amino acids Chemical class 0.000 claims description 42
- 239000000017 hydrogel Substances 0.000 claims description 28
- 239000012530 fluid Substances 0.000 claims description 27
- 238000006243 chemical reaction Methods 0.000 claims description 22
- 239000007853 buffer solution Substances 0.000 claims description 10
- 208000030159 metabolic disease Diseases 0.000 claims description 7
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 6
- 238000004891 communication Methods 0.000 claims description 6
- 208000016097 disease of metabolism Diseases 0.000 claims description 6
- 230000001580 bacterial effect Effects 0.000 claims description 5
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 4
- 238000001962 electrophoresis Methods 0.000 claims description 4
- 239000001632 sodium acetate Substances 0.000 claims description 4
- 235000017281 sodium acetate Nutrition 0.000 claims description 4
- 229920002307 Dextran Polymers 0.000 claims description 3
- 239000003054 catalyst Substances 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 230000001143 conditioned effect Effects 0.000 claims description 2
- 238000000338 in vitro Methods 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 6
- 230000004224 protection Effects 0.000 claims 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 3
- 102100034184 Macrophage scavenger receptor types I and II Human genes 0.000 claims 3
- 101710134306 Macrophage scavenger receptor types I and II Proteins 0.000 claims 3
- 229910052708 sodium Inorganic materials 0.000 claims 3
- 239000011780 sodium chloride Substances 0.000 claims 3
- YQUVCSBJEUQKSH-UHFFFAOYSA-N 3,4-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C(O)=C1 YQUVCSBJEUQKSH-UHFFFAOYSA-N 0.000 claims 2
- YEESUBCSWGVPCE-UHFFFAOYSA-N azanylidyneoxidanium iron(2+) pentacyanide Chemical compound [Fe++].[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.N#[O+] YEESUBCSWGVPCE-UHFFFAOYSA-N 0.000 claims 2
- 235000013405 beer Nutrition 0.000 claims 2
- 229960002460 nitroprusside Drugs 0.000 claims 2
- 150000002989 phenols Chemical class 0.000 claims 2
- KJCVRFUGPWSIIH-UHFFFAOYSA-N 1-naphthol Chemical compound C1=CC=C2C(O)=CC=CC2=C1 KJCVRFUGPWSIIH-UHFFFAOYSA-N 0.000 claims 1
- GNBRZRRANUHHGT-UHFFFAOYSA-N 1-phenylcyclohexa-2,4-dien-1-ol Chemical compound C=1C=CC=CC=1C1(O)CC=CC=C1 GNBRZRRANUHHGT-UHFFFAOYSA-N 0.000 claims 1
- GICIECWTEWJCRE-UHFFFAOYSA-N 3,4,4,7-tetramethyl-2,3-dihydro-1h-naphthalene Chemical compound CC1=CC=C2C(C)(C)C(C)CCC2=C1 GICIECWTEWJCRE-UHFFFAOYSA-N 0.000 claims 1
- IBGBGRVKPALMCQ-UHFFFAOYSA-N 3,4-Dihydroxybenzaldehyde Natural products OC1=CC=C(C=O)C=C1O IBGBGRVKPALMCQ-UHFFFAOYSA-N 0.000 claims 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims 1
- 102100023245 Asparagine-tRNA ligase, cytoplasmic Human genes 0.000 claims 1
- 241000726103 Atta Species 0.000 claims 1
- 101100452784 Caenorhabditis elegans ire-1 gene Proteins 0.000 claims 1
- 101100150284 Caenorhabditis elegans sre-8 gene Proteins 0.000 claims 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims 1
- 241000196324 Embryophyta Species 0.000 claims 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims 1
- 241000238558 Eucarida Species 0.000 claims 1
- 102000015212 Fas Ligand Protein Human genes 0.000 claims 1
- 108010039471 Fas Ligand Protein Proteins 0.000 claims 1
- 101000624939 Homo sapiens Asparagine-tRNA ligase, cytoplasmic Proteins 0.000 claims 1
- 229920000057 Mannan Polymers 0.000 claims 1
- 101100033673 Mus musculus Ren1 gene Proteins 0.000 claims 1
- 239000004698 Polyethylene Substances 0.000 claims 1
- 208000009989 Posterior Leukoencephalopathy Syndrome Diseases 0.000 claims 1
- 240000003834 Triticum spelta Species 0.000 claims 1
- ZOIORXHNWRGPMV-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O.CC(O)=O ZOIORXHNWRGPMV-UHFFFAOYSA-N 0.000 claims 1
- YBCVMFKXIKNREZ-UHFFFAOYSA-N acoh acetic acid Chemical compound CC(O)=O.CC(O)=O YBCVMFKXIKNREZ-UHFFFAOYSA-N 0.000 claims 1
- LLEMOWNGBBNAJR-UHFFFAOYSA-N biphenyl-2-ol Chemical compound OC1=CC=CC=C1C1=CC=CC=C1 LLEMOWNGBBNAJR-UHFFFAOYSA-N 0.000 claims 1
- 239000011575 calcium Substances 0.000 claims 1
- BSEHISUIPNKWKT-UHFFFAOYSA-L calcium;zinc;dichloride Chemical group [Cl-].[Cl-].[Ca+2].[Zn+2] BSEHISUIPNKWKT-UHFFFAOYSA-L 0.000 claims 1
- 235000013351 cheese Nutrition 0.000 claims 1
- 230000001419 dependent effect Effects 0.000 claims 1
- 210000005069 ears Anatomy 0.000 claims 1
- 238000005516 engineering process Methods 0.000 claims 1
- 229920001684 low density polyethylene Polymers 0.000 claims 1
- 239000004702 low-density polyethylene Substances 0.000 claims 1
- 229920003936 perfluorinated ionomer Polymers 0.000 claims 1
- 235000020030 perry Nutrition 0.000 claims 1
- 239000004576 sand Substances 0.000 claims 1
- 108091007551 scavenger receptor class L Proteins 0.000 claims 1
- BHZOKUMUHVTPBX-UHFFFAOYSA-M sodium acetic acid acetate Chemical compound [Na+].CC(O)=O.CC([O-])=O BHZOKUMUHVTPBX-UHFFFAOYSA-M 0.000 claims 1
- 239000013589 supplement Substances 0.000 claims 1
- 238000004416 surface enhanced Raman spectroscopy Methods 0.000 claims 1
- 239000004246 zinc acetate Substances 0.000 claims 1
- RSAZYXZUJROYKR-UHFFFAOYSA-N indophenol Chemical compound C1=CC(O)=CC=C1N=C1C=CC(=O)C=C1 RSAZYXZUJROYKR-UHFFFAOYSA-N 0.000 abstract description 36
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 10
- 238000004817 gas chromatography Methods 0.000 abstract description 2
- 229920000554 ionomer Polymers 0.000 abstract 2
- 239000000523 sample Substances 0.000 description 109
- 235000001014 amino acid Nutrition 0.000 description 41
- 108090000790 Enzymes Proteins 0.000 description 35
- 102000004190 Enzymes Human genes 0.000 description 35
- 238000012360 testing method Methods 0.000 description 23
- 239000012634 fragment Substances 0.000 description 22
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 19
- 150000001875 compounds Chemical class 0.000 description 17
- 239000010839 body fluid Substances 0.000 description 16
- 239000000243 solution Substances 0.000 description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 230000002503 metabolic effect Effects 0.000 description 10
- 239000000376 reactant Substances 0.000 description 10
- 239000007795 chemical reaction product Substances 0.000 description 9
- 150000002500 ions Chemical class 0.000 description 9
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 8
- 229940072056 alginate Drugs 0.000 description 8
- 229920000615 alginic acid Polymers 0.000 description 8
- 235000010443 alginic acid Nutrition 0.000 description 8
- 239000003638 chemical reducing agent Substances 0.000 description 8
- 239000000499 gel Substances 0.000 description 8
- 201000010099 disease Diseases 0.000 description 7
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 239000002207 metabolite Substances 0.000 description 5
- 238000012544 monitoring process Methods 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- 239000003929 acidic solution Substances 0.000 description 4
- 230000000975 bioactive effect Effects 0.000 description 4
- 230000006735 deficit Effects 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 4
- 108010078226 phenylalanine oxidase Proteins 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- 108010093096 Immobilized Enzymes Proteins 0.000 description 3
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 239000003637 basic solution Substances 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000007791 liquid phase Substances 0.000 description 3
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000007790 solid phase Substances 0.000 description 3
- 241000894007 species Species 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 2
- JESXATFQYMPTNL-UHFFFAOYSA-N 2-ethenylphenol Chemical compound OC1=CC=CC=C1C=C JESXATFQYMPTNL-UHFFFAOYSA-N 0.000 description 2
- RBTBFTRPCNLSDE-UHFFFAOYSA-N 3,7-bis(dimethylamino)phenothiazin-5-ium Chemical compound C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 RBTBFTRPCNLSDE-UHFFFAOYSA-N 0.000 description 2
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 2
- 101000950981 Bacillus subtilis (strain 168) Catabolic NAD-specific glutamate dehydrogenase RocG Proteins 0.000 description 2
- 101710088194 Dehydrogenase Proteins 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 206010016654 Fibrosis Diseases 0.000 description 2
- 241000626621 Geobacillus Species 0.000 description 2
- 102000016901 Glutamate dehydrogenase Human genes 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- 108090000854 Oxidoreductases Proteins 0.000 description 2
- 102000004316 Oxidoreductases Human genes 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 229910021607 Silver chloride Inorganic materials 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000012670 alkaline solution Substances 0.000 description 2
- 239000003011 anion exchange membrane Substances 0.000 description 2
- VSGNNIFQASZAOI-UHFFFAOYSA-L calcium acetate Chemical compound [Ca+2].CC([O-])=O.CC([O-])=O VSGNNIFQASZAOI-UHFFFAOYSA-L 0.000 description 2
- 239000001639 calcium acetate Substances 0.000 description 2
- 235000011092 calcium acetate Nutrition 0.000 description 2
- 229960005147 calcium acetate Drugs 0.000 description 2
- 238000005341 cation exchange Methods 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 125000004386 diacrylate group Chemical group 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 238000005534 hematocrit Methods 0.000 description 2
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical compound Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 description 2
- 235000015110 jellies Nutrition 0.000 description 2
- 239000008274 jelly Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 229960000907 methylthioninium chloride Drugs 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 238000004445 quantitative analysis Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229950003937 tolonium Drugs 0.000 description 2
- HNONEKILPDHFOL-UHFFFAOYSA-M tolonium chloride Chemical compound [Cl-].C1=C(C)C(N)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 HNONEKILPDHFOL-UHFFFAOYSA-M 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- 229940061334 2-phenylphenol Drugs 0.000 description 1
- 108010031025 Alanine Dehydrogenase Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 108091006149 Electron carriers Proteins 0.000 description 1
- 101001130226 Homo sapiens Phosphatidylcholine-sterol acyltransferase Proteins 0.000 description 1
- 208000028547 Inborn Urea Cycle disease Diseases 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- 108010028658 Leucine Dehydrogenase Proteins 0.000 description 1
- 241001435619 Lile Species 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- 102000008109 Mixed Function Oxygenases Human genes 0.000 description 1
- 108010074633 Mixed Function Oxygenases Proteins 0.000 description 1
- BAWFJGJZGIEFAR-NNYOXOHSSA-O NAD(+) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-O 0.000 description 1
- 229920000557 Nafion® Polymers 0.000 description 1
- 102100031538 Phosphatidylcholine-sterol acyltransferase Human genes 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 208000037863 aminoacidopathy Diseases 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000001851 biosynthetic effect Effects 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- VDQQXEISLMTGAB-UHFFFAOYSA-N chloramine T Chemical compound [Na+].CC1=CC=C(S(=O)(=O)[N-]Cl)C=C1 VDQQXEISLMTGAB-UHFFFAOYSA-N 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 230000008133 cognitive development Effects 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000001434 dietary modification Nutrition 0.000 description 1
- XEYBHCRIKKKOSS-UHFFFAOYSA-N disodium;azanylidyneoxidanium;iron(2+);pentacyanide Chemical compound [Na+].[Na+].[Fe+2].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].[O+]#N XEYBHCRIKKKOSS-UHFFFAOYSA-N 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 238000005558 fluorometry Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000000099 in vitro assay Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000005462 in vivo assay Methods 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 230000007472 neurodevelopment Effects 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000012123 point-of-care testing Methods 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000006479 redox reaction Methods 0.000 description 1
- 239000013074 reference sample Substances 0.000 description 1
- 102000037983 regulatory factors Human genes 0.000 description 1
- 108091008025 regulatory factors Proteins 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000010865 sewage Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000004885 tandem mass spectrometry Methods 0.000 description 1
- KUUVQVSHGLHAKZ-UHFFFAOYSA-N thionine Chemical compound C=1C=CC=CSC=CC=1 KUUVQVSHGLHAKZ-UHFFFAOYSA-N 0.000 description 1
- 208000030954 urea cycle disease Diseases 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 238000001429 visible spectrum Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01J—MEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRARED, VISIBLE OR ULTRAVIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY
- G01J3/00—Spectrometry; Spectrophotometry; Monochromators; Measuring colours
- G01J3/28—Investigating the spectrum
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
- G01N21/77—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
- G01N21/78—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator producing a change of colour
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/28—Electrolytic cell components
- G01N27/30—Electrodes, e.g. test electrodes; Half-cells
- G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/28—Electrolytic cell components
- G01N27/30—Electrodes, e.g. test electrodes; Half-cells
- G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
- G01N27/3275—Sensing specific biomolecules, e.g. nucleic acid strands, based on an electrode surface reaction
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
- G01N33/4925—Blood measuring blood gas content, e.g. O2, CO2, HCO3
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/84—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Electrochemistry (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Ecology (AREA)
- Biophysics (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Plasma & Fusion (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361872149P | 2013-08-30 | 2013-08-30 | |
| PCT/US2014/053756 WO2015031911A1 (en) | 2013-08-30 | 2014-09-02 | Device and methods of using device for detection of hyperammonemia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SA516370640B1 true SA516370640B1 (ar) | 2019-02-24 |
Family
ID=52587421
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SA516370640A SA516370640B1 (ar) | 2013-08-30 | 2016-02-28 | وسيلة وطرق لاستخدام الوسيلة للكشف عن فرط أمونيا الدم |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US9952199B2 (enExample) |
| EP (2) | EP3039422B1 (enExample) |
| JP (1) | JP6646579B2 (enExample) |
| KR (1) | KR102278346B1 (enExample) |
| CN (1) | CN105940300B (enExample) |
| AU (1) | AU2014311977B2 (enExample) |
| BR (1) | BR112016004320B1 (enExample) |
| CA (1) | CA2922821C (enExample) |
| CL (1) | CL2016000467A1 (enExample) |
| DK (2) | DK3540429T3 (enExample) |
| IL (1) | IL244274B (enExample) |
| MX (1) | MX2016002632A (enExample) |
| SA (1) | SA516370640B1 (enExample) |
| TR (1) | TR201903528T4 (enExample) |
| WO (1) | WO2015031911A1 (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20160092653A1 (en) * | 2014-09-30 | 2016-03-31 | Koninklijke Philips N.V. | NUTRITIONAL INTAKE VIEWER (NutriWeb) |
| WO2016176366A1 (en) * | 2015-04-27 | 2016-11-03 | University Of Maryland, College Park | Device and methods of using device for detection of hyperammonemia |
| US10792339B2 (en) | 2015-07-17 | 2020-10-06 | Children's National Medical Center | Methods and compositions for treating phenylketonuria |
| CA3026706C (en) | 2016-08-16 | 2024-01-09 | Eth Zurich | Transmembrane ph-gradient polymersomes and their use in the scavenging of ammonia and its methylated analogs |
| KR101920272B1 (ko) * | 2016-11-22 | 2018-11-20 | (주)인트인 | 조명이 개선된 체액 검사장치 |
| PL3668927T3 (pl) * | 2017-09-12 | 2024-06-24 | Eth Zurich | Przezbłonowe polimerosomy z gradientem pH do ilościowego oznaczania amoniaku w płynach ustrojowych |
| KR20250103785A (ko) * | 2018-01-12 | 2025-07-07 | 아리조나 보드 오브 리젠츠 온 비하프 오브 아리조나 스테이트 유니버시티 | 체액 중의 암모니아 및 암모늄의 검출 및 정량화를 위한 시스템 및 방법 |
| WO2020186362A1 (en) * | 2019-03-20 | 2020-09-24 | Mcmaster University | Differential signal biosensing for detecting an analyte |
| US11156991B2 (en) | 2019-06-24 | 2021-10-26 | Nanotronics Imaging, Inc. | Predictive process control for a manufacturing process |
| US20220364076A1 (en) * | 2019-07-02 | 2022-11-17 | The Texas A&M University System | Microfluidic platform for selective exosome isolation |
| WO2021055792A1 (en) * | 2019-09-20 | 2021-03-25 | The Board Of Trustees Of The Leland Stanford Junior University | Electrochemical pre-concentration for improved detection of gaseous species in water |
| AU2020370511A1 (en) * | 2019-10-23 | 2022-06-09 | President And Fellows Of Harvard College | Sensing devices based on microneedle arrays for sensing applications including ketone bodies monitoring |
| CN110806448B (zh) * | 2019-11-21 | 2022-03-22 | 北京市药品检验所 | 测定复方氨基酸注射液中游离氨的方法 |
| KR102369697B1 (ko) * | 2020-05-18 | 2022-03-03 | 국민대학교산학협력단 | 바이오 센싱 모듈, 바이오 센싱 장치, 및 이를 포함하는 바이오 센싱 시스템 |
| WO2022008714A1 (en) * | 2020-07-10 | 2022-01-13 | Radiometer Medical Aps | A blood gas analyzer and a system comprising a blood gas analyzer, and use thereof |
| EP3968009B1 (en) * | 2020-09-10 | 2024-11-06 | Hach Lange GmbH | Method for determining ammonium |
| US20250000957A1 (en) * | 2021-09-16 | 2025-01-02 | Arcturus Therapeutics, Inc. | Compositions and methods for treating phenylketonuria |
| EP4449118A4 (en) | 2021-12-14 | 2025-04-02 | Gazi Universitesi Rektorlugu | Biosensor system for quantitative measurement of phenylalanine from blood |
| CN114088026B (zh) * | 2022-01-20 | 2022-04-05 | 江苏奥琳斯邦装备科技股份有限公司 | 一种应变测量的热压固化装置以及固化方法 |
| US12030045B1 (en) | 2023-01-05 | 2024-07-09 | Sequitur Health Corp. | Devices, methods, and systems for deriving ammonia gas from whole blood |
| US12140534B2 (en) | 2023-01-05 | 2024-11-12 | Sequitur Health Corp. | Devices, methods, and systems for deriving a permeate from a feed solution |
| GB2633752A (en) * | 2023-09-14 | 2025-03-26 | Palintest Ltd | Electrochemical detection of monochloramine and/or ammonia |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5786053A (en) * | 1980-11-18 | 1982-05-28 | Yokogawa Hokushin Electric Corp | Method and device for measuring amino compound |
| JPS59187249A (ja) * | 1983-04-07 | 1984-10-24 | Fuji Electric Corp Res & Dev Ltd | 尿素窒素分析装置 |
| JPS63218860A (ja) * | 1987-03-07 | 1988-09-12 | Aoki Hiroko | 溶液中のアンモニアの定量方法 |
| US5128015A (en) | 1988-03-15 | 1992-07-07 | Tall Oak Ventures | Method and apparatus for amperometric diagnostic analysis |
| JP2739484B2 (ja) * | 1988-09-29 | 1998-04-15 | 株式会社ヤトロン | 自動分析装置用尿素窒素測定試薬 |
| JPH02104272A (ja) * | 1988-10-12 | 1990-04-17 | Ricoh Co Ltd | 液体検出装置 |
| US5243516A (en) | 1989-12-15 | 1993-09-07 | Boehringer Mannheim Corporation | Biosensing instrument and method |
| US4999582A (en) | 1989-12-15 | 1991-03-12 | Boehringer Mannheim Corp. | Biosensor electrode excitation circuit |
| US4963814A (en) | 1989-12-15 | 1990-10-16 | Boehringer Mannheim Corporation | Regulated bifurcated power supply |
| US4999632A (en) | 1989-12-15 | 1991-03-12 | Boehringer Mannheim Corporation | Analog to digital conversion with noise reduction |
| DE4318519C2 (de) | 1993-06-03 | 1996-11-28 | Fraunhofer Ges Forschung | Elektrochemischer Sensor |
| JP2704046B2 (ja) | 1993-06-08 | 1998-01-26 | ベーリンガー マンハイム コーポレーション | 適切な電極の接続を検出し、サンプル片及びチェック片を区別するバイオセンシングメータ |
| US5366609A (en) | 1993-06-08 | 1994-11-22 | Boehringer Mannheim Corporation | Biosensing meter with pluggable memory key |
| US5405511A (en) | 1993-06-08 | 1995-04-11 | Boehringer Mannheim Corporation | Biosensing meter with ambient temperature estimation method and system |
| US5352351A (en) | 1993-06-08 | 1994-10-04 | Boehringer Mannheim Corporation | Biosensing meter with fail/safe procedures to prevent erroneous indications |
| US5762770A (en) | 1994-02-21 | 1998-06-09 | Boehringer Mannheim Corporation | Electrochemical biosensor test strip |
| AU2365895A (en) * | 1994-04-26 | 1995-11-16 | Regents Of The University Of Michigan, The | Unitary sandwich enzyme immunoassay cassette, device and method of use |
| US5624537A (en) | 1994-09-20 | 1997-04-29 | The University Of British Columbia - University-Industry Liaison Office | Biosensor and interface membrane |
| US5698083A (en) | 1995-08-18 | 1997-12-16 | Regents Of The University Of California | Chemiresistor urea sensor |
| JPH09271398A (ja) * | 1996-02-09 | 1997-10-21 | Asahi Chem Ind Co Ltd | アンモニア測定法および測定用組成物 |
| JP2000146899A (ja) | 1998-11-06 | 2000-05-26 | Horiba Ltd | アンモニウムイオン測定装置 |
| ES2224614T3 (es) | 1999-03-19 | 2005-03-01 | Sapporo Immuno Diagnostic Laboratory | Procedimiento de analisis de substrato y biosensor. |
| US6645359B1 (en) | 2000-10-06 | 2003-11-11 | Roche Diagnostics Corporation | Biosensor |
| US6662439B1 (en) | 1999-10-04 | 2003-12-16 | Roche Diagnostics Corporation | Laser defined features for patterned laminates and electrodes |
| CA2453141A1 (en) * | 2001-07-09 | 2003-01-23 | Arizona Board Of Regents A Body Corporate Acting On Behalf Of Arizona State University | Afinity biosensor for monitoring of biological process |
| US7150975B2 (en) * | 2002-08-19 | 2006-12-19 | Animas Technologies, Llc | Hydrogel composition for measuring glucose flux |
| US9101302B2 (en) | 2004-05-03 | 2015-08-11 | Abbott Diabetes Care Inc. | Analyte test device |
| JP2006126092A (ja) * | 2004-10-29 | 2006-05-18 | Ntt Advanced Technology Corp | 薄層流路および透析膜を有する微小バイオセンサ |
| US8409864B2 (en) * | 2006-01-06 | 2013-04-02 | Renal Solutions, Inc. | Ammonia sensor and system for use |
| US20090294302A1 (en) * | 2008-05-28 | 2009-12-03 | John Pasqua | Use of Alginate to Reduce Hematocrit Bias in Biosensors |
| JP2010160134A (ja) * | 2008-12-11 | 2010-07-22 | Unitika Ltd | 検知材および定量方法 |
| JP2014010145A (ja) | 2012-07-02 | 2014-01-20 | Aquatech Co Ltd | 液中アンモニアを検知し、反応を制御する装置 |
-
2014
- 2014-09-02 DK DK19150428.1T patent/DK3540429T3/da active
- 2014-09-02 EP EP14841207.5A patent/EP3039422B1/en active Active
- 2014-09-02 JP JP2016537941A patent/JP6646579B2/ja active Active
- 2014-09-02 CN CN201480057514.9A patent/CN105940300B/zh active Active
- 2014-09-02 EP EP19150428.1A patent/EP3540429B1/en active Active
- 2014-09-02 TR TR2019/03528T patent/TR201903528T4/tr unknown
- 2014-09-02 KR KR1020167008373A patent/KR102278346B1/ko active Active
- 2014-09-02 US US14/915,602 patent/US9952199B2/en active Active
- 2014-09-02 CA CA2922821A patent/CA2922821C/en active Active
- 2014-09-02 AU AU2014311977A patent/AU2014311977B2/en active Active
- 2014-09-02 BR BR112016004320-0A patent/BR112016004320B1/pt active IP Right Grant
- 2014-09-02 DK DK14841207.5T patent/DK3039422T3/en active
- 2014-09-02 WO PCT/US2014/053756 patent/WO2015031911A1/en not_active Ceased
- 2014-09-02 MX MX2016002632A patent/MX2016002632A/es active IP Right Grant
-
2016
- 2016-02-24 IL IL244274A patent/IL244274B/en active IP Right Grant
- 2016-02-28 SA SA516370640A patent/SA516370640B1/ar unknown
- 2016-02-29 CL CL2016000467A patent/CL2016000467A1/es unknown
-
2018
- 2018-03-23 US US15/933,834 patent/US10620187B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CL2016000467A1 (es) | 2016-10-28 |
| US20180284099A1 (en) | 2018-10-04 |
| EP3039422B1 (en) | 2019-01-09 |
| JP6646579B2 (ja) | 2020-02-14 |
| DK3540429T3 (da) | 2021-02-15 |
| US9952199B2 (en) | 2018-04-24 |
| EP3540429A1 (en) | 2019-09-18 |
| IL244274A0 (en) | 2016-04-21 |
| IL244274B (en) | 2020-09-30 |
| CN105940300B (zh) | 2019-01-22 |
| KR20160048204A (ko) | 2016-05-03 |
| EP3540429B1 (en) | 2020-11-11 |
| US10620187B2 (en) | 2020-04-14 |
| BR112016004320A2 (pt) | 2017-10-24 |
| JP2016529515A (ja) | 2016-09-23 |
| EP3039422A4 (en) | 2017-04-19 |
| BR112016004320B1 (pt) | 2022-03-03 |
| TR201903528T4 (tr) | 2019-04-22 |
| AU2014311977B2 (en) | 2019-02-21 |
| KR102278346B1 (ko) | 2021-07-19 |
| AU2014311977A1 (en) | 2016-03-17 |
| CN105940300A (zh) | 2016-09-14 |
| CA2922821C (en) | 2023-01-03 |
| CA2922821A1 (en) | 2015-03-05 |
| WO2015031911A1 (en) | 2015-03-05 |
| US20160231310A1 (en) | 2016-08-11 |
| MX2016002632A (es) | 2016-10-04 |
| DK3039422T3 (en) | 2019-03-25 |
| EP3039422A1 (en) | 2016-07-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SA516370640B1 (ar) | وسيلة وطرق لاستخدام الوسيلة للكشف عن فرط أمونيا الدم | |
| JP2016529515A5 (enExample) | ||
| CN103805170B (zh) | 一种用于识别硫化氢的特异性荧光探针及其应用 | |
| JP5829766B2 (ja) | 酵素法を利用したヘモグロビンＡ１ｃ定量分析のための溶血試薬組成物 | |
| ElKaoutit et al. | A comparison of three amperometric phenoloxidase–Sonogel–Carbon based biosensors for determination of polyphenols in beers | |
| EP3517966B1 (en) | Reagent composition for measuring glycated hemoglobin and method for measuring glycated hemoglobin using same | |
| Li et al. | Glucose biosensor based on the room-temperature phosphorescence of TiO2/SiO2 nanocomposite | |
| CN108276990A (zh) | 一种区分GSH、Cys、NAC荧光探针及其制备方法和应用 | |
| JP4520999B2 (ja) | ポリマー電解質、電気化学的測定用の半電池、およびこれらの使用 | |
| CN103472055B (zh) | 基于纳米金形成的可视化检测过氧化氢酶的方法 | |
| Pavão e Pavão et al. | A Simple, Cost‐effective, and Environmentally Friendly Method for Determination of Ciprofloxacin in Drugs and Urine Samples Based on Electrogenerated Chemiluminescence | |
| CN107084938B (zh) | 基于壳聚糖-铂模拟氧化酶的碱性磷酸酶测定方法 | |
| Cavalieri et al. | Studies on the Structure of Nucleic Acids. VI. The Kinetics of Desoxyribonuclease Action1 | |
| CN109971463B (zh) | 一种检测细胞内溶酶体no的比率型荧光探针及其应用 | |
| CN106967721A (zh) | Atp核酸适配体、利用纳米金显色检测atp的方法及试剂盒 | |
| KR102802646B1 (ko) | 시료 내 바이오마커를 이용하는 질병 자가 진단 장치 | |
| López et al. | A sensitive glucose biosensor based on brushite, a biocompatible cement | |
| Zhou et al. | Advanced electrochemical strategy for in vivo detection of electrochemically inactive molecules | |
| CN111088320A (zh) | α-L-岩藻糖苷酶测定试剂 | |
| Vymazalová et al. | Photocolorimetric biosensor for detection of cholinergic organophosphorus compounds | |
| US11268953B2 (en) | Reagent composition for measuring glycated hemoglobin and method for measuring glycated hemoglobin using same | |
| KR20240062120A (ko) | 바이오마커 검출체, 그의 제조방법, 및 바이오마커 검출방법 | |
| EP0753742B1 (en) | Stable liquid urobilinogen control composition | |
| Baker | Glucose Oxidase and Prussian Blue Nanoparticles Encapsulated within a Xerogel for Electrochemical Detection of Glucose | |
| KR101496411B1 (ko) | 산소 측정용 미세전극의 보정 방법 |